{"transactions":[{"id":4623611,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-21T21:23:41.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":false,"shares":3982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, originally for 185,000 shares, vested as to one-fourth of the shares on February 13, 2025, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":181018,"derivative":{"exercise_price":14.85,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":3982},"source":{"system":"sec-edgar","filing":"0001882764-26-000008","document":"form4-09212026_090936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1882764/000188276426000008/form4-09212026_090936.xml","form_type":"4"}},{"id":4623610,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-21T21:23:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":289,"price":51.4929,"value":14881.4481,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $51.365 to $51.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001882764-26-000008","document":"form4-09212026_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1882764/000188276426000008/form4-09212026_090936.xml","form_type":"4"}},{"id":4623609,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-21T21:23:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":2194,"price":50.7158,"value":111270.4652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $50.31 to $51.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":38289,"source":{"system":"sec-edgar","filing":"0001882764-26-000008","document":"form4-09212026_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882764/000188276426000008/form4-09212026_090936.xml","form_type":"4"}},{"id":4623608,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-21T21:23:41.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":3535,"price":50.0286,"value":176851.101,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $49.31 to $50.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":40483,"source":{"system":"sec-edgar","filing":"0001882764-26-000008","document":"form4-09212026_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882764/000188276426000008/form4-09212026_090936.xml","form_type":"4"}},{"id":4623607,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-21T21:23:41.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":true,"shares":3982,"price":14.85,"value":59132.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":44018,"source":{"system":"sec-edgar","filing":"0001882764-26-000008","document":"form4-09212026_090936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882764/000188276426000008/form4-09212026_090936.xml","form_type":"4"}},{"id":681397,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-19T20:17:49.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":1388,"price":59.3536,"value":82382.7968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $58.945 to $59.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":40036,"source":{"system":"sec-edgar","filing":"0001882764-26-000007","document":"form4-08192026_080843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000007/form4-08192026_080843.xml","form_type":"4"}},{"id":681396,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-19T20:17:49.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":4630,"price":58.3517,"value":270168.371,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $57.895 to $58.89. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":41424,"source":{"system":"sec-edgar","filing":"0001882764-26-000007","document":"form4-08192026_080843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000007/form4-08192026_080843.xml","form_type":"4"}},{"id":705199,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"exercise","planned":true,"acquired":false,"shares":1072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":84966,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1072},"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705198,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":123,"price":53.8716,"value":6626.2068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $53.78 to $53.9781. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":46054,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705197,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":2638,"price":53.3825,"value":140823.035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $52.77 to $53.7685. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":46177,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705196,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":2564,"price":52.318,"value":134143.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $51.77 to $52.7695. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":48815,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705195,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":369,"price":51.4823,"value":18996.9687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $50.765 to $51.7481. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":51379,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705194,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":324,"price":49.9715,"value":16190.766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $49.72 to $50.3778. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":51748,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":705193,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-21T21:24:30.000Z","date":"2026-07-17","kind":"exercise","planned":true,"acquired":true,"shares":1072,"price":2.48,"value":2658.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":52072,"source":{"system":"sec-edgar","filing":"0001882764-26-000006","document":"form4-07212026_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000006/form4-07212026_090724.xml","form_type":"4"}},{"id":730490,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T21:13:12.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":6018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":86038,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":6018},"source":{"system":"sec-edgar","filing":"0001882764-26-000005","document":"form4-06222026_090607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/form4-06222026_090607.xml","form_type":"4"}},{"id":730489,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:13:12.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1238,"price":44.7475,"value":55397.405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $44.3548 to $44.945. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001882764-26-000005","document":"form4-06222026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/form4-06222026_090607.xml","form_type":"4"}},{"id":730488,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:13:12.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":3401,"price":43.8634,"value":149179.4234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $43.3342 to $44.3142. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":52238,"source":{"system":"sec-edgar","filing":"0001882764-26-000005","document":"form4-06222026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/form4-06222026_090607.xml","form_type":"4"}},{"id":730487,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:13:12.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1379,"price":42.785,"value":59000.515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $42.295 to $43.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":55639,"source":{"system":"sec-edgar","filing":"0001882764-26-000005","document":"form4-06222026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/form4-06222026_090607.xml","form_type":"4"}},{"id":730486,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:13:12.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":6018,"price":2.48,"value":14924.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":57018,"source":{"system":"sec-edgar","filing":"0001882764-26-000005","document":"form4-06222026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/form4-06222026_090607.xml","form_type":"4"}},{"id":850945,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T22:15:22.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":29.5839,"value":295839.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $29.43 to $29.7867. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001882764-26-000002","document":"form4-03102026_100318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000002/form4-03102026_100318.xml","form_type":"4"}},{"id":901013,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T00:49:32.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":150000,"derivative":{"exercise_price":27.16,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001882764-26-000001","document":"form4-02182026_120228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000001/form4-02182026_120228.xml","form_type":"4"}},{"id":901012,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-18T00:49:32.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":61000,"source":{"system":"sec-edgar","filing":"0001882764-26-000001","document":"form4-02182026_120228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276426000001/form4-02182026_120228.xml","form_type":"4"}},{"id":959652,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T23:47:17.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":92056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001882764-25-000005","document":"form4-12232025_111212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276425000005/form4-12232025_111212.xml","form_type":"4"}},{"id":959651,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T23:47:17.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":2.48,"value":32240.0,"ownership":{"direct":true},"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001882764-25-000005","document":"form4-12232025_111212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276425000005/form4-12232025_111212.xml","form_type":"4"}},{"id":1029286,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-01T20:46:31.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":105056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001882764-25-000004","document":"form4-10012025_081027.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276425000004/form4-10012025_081027.xml","form_type":"4"}},{"id":1029285,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-01T20:46:31.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":20.3973,"value":66291.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.025 to $20.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001882764-25-000004","document":"form4-10012025_081027.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276425000004/form4-10012025_081027.xml","form_type":"4"}},{"id":1029284,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-01T20:46:31.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001882764-25-000004","document":"form4-10012025_081027.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000188276425000004/form4-10012025_081027.xml","form_type":"4"}},{"id":1052899,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-29T21:03:17.000Z","date":"2025-08-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":108306,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-023310","document":"form4-08292025_090813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925023310/form4-08292025_090813.xml","form_type":"4"}},{"id":1052898,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-29T21:03:17.000Z","date":"2025-08-27","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":20.6273,"value":67038.725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.27 to $20.8689. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-023310","document":"form4-08292025_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925023310/form4-08292025_090813.xml","form_type":"4"}},{"id":1052897,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-29T21:03:17.000Z","date":"2025-08-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-023310","document":"form4-08292025_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925023310/form4-08292025_090813.xml","form_type":"4"}},{"id":1079104,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-30T21:57:52.000Z","date":"2025-07-28","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":111556,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-020605","document":"form4-07302025_090748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925020605/form4-07302025_090748.xml","form_type":"4"}},{"id":1079103,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-30T21:57:52.000Z","date":"2025-07-28","kind":"sale","planned":true,"acquired":false,"shares":65,"price":21.3003,"value":1384.5195,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.1377 to $21.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-020605","document":"form4-07302025_090748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925020605/form4-07302025_090748.xml","form_type":"4"}},{"id":1079102,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-30T21:57:52.000Z","date":"2025-07-28","kind":"sale","planned":true,"acquired":false,"shares":3185,"price":20.4456,"value":65119.236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.09 to $21.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23065,"source":{"system":"sec-edgar","filing":"0001415889-25-020605","document":"form4-07302025_090748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925020605/form4-07302025_090748.xml","form_type":"4"}},{"id":1079101,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-30T21:57:52.000Z","date":"2025-07-28","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-020605","document":"form4-07302025_090748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925020605/form4-07302025_090748.xml","form_type":"4"}},{"id":1088023,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-14T21:07:34.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":114806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-25-019730","document":"form4-07142025_090730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925019730/form4-07142025_090730.xml","form_type":"4"}},{"id":1088022,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-14T21:07:34.000Z","date":"2025-07-10","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":22.655,"value":22655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.59 to $22.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-019730","document":"form4-07142025_090730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925019730/form4-07142025_090730.xml","form_type":"4"}},{"id":1088021,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-14T21:07:34.000Z","date":"2025-07-10","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":2.48,"value":2480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001415889-25-019730","document":"form4-07142025_090730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925019730/form4-07142025_090730.xml","form_type":"4"}},{"id":1097844,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-01T20:42:33.000Z","date":"2025-06-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":115806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-018718","document":"form4-07012025_080730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925018718/form4-07012025_080730.xml","form_type":"4"}},{"id":1097843,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-01T20:42:33.000Z","date":"2025-06-27","kind":"sale","planned":true,"acquired":false,"shares":198,"price":21.6583,"value":4288.3434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.5811 to $21.788. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-018718","document":"form4-07012025_080730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925018718/form4-07012025_080730.xml","form_type":"4"}},{"id":1097842,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-01T20:42:33.000Z","date":"2025-06-27","kind":"sale","planned":true,"acquired":false,"shares":3052,"price":20.8609,"value":63667.4668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.58 to $21.575. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23198,"source":{"system":"sec-edgar","filing":"0001415889-25-018718","document":"form4-07012025_080730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925018718/form4-07012025_080730.xml","form_type":"4"}},{"id":1097841,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-01T20:42:33.000Z","date":"2025-06-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-018718","document":"form4-07012025_080730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925018718/form4-07012025_080730.xml","form_type":"4"}},{"id":1107984,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T20:24:09.000Z","date":"2025-06-13","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":119056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-25-017532","document":"form4-06172025_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925017532/form4-06172025_080605.xml","form_type":"4"}},{"id":1107983,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-17T20:24:09.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":22.5518,"value":67655.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.50 to $22.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-017532","document":"form4-06172025_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925017532/form4-06172025_080605.xml","form_type":"4"}},{"id":1107982,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-17T20:24:09.000Z","date":"2025-06-13","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.48,"value":7440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001415889-25-017532","document":"form4-06172025_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925017532/form4-06172025_080605.xml","form_type":"4"}},{"id":1130561,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T21:38:28.000Z","date":"2025-05-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":122056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-014913","document":"form4-05292025_090525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925014913/form4-05292025_090525.xml","form_type":"4"}},{"id":1130560,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-29T21:38:28.000Z","date":"2025-05-27","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":16.1826,"value":52593.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.925 to $16.675. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-014913","document":"form4-05292025_090525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925014913/form4-05292025_090525.xml","form_type":"4"}},{"id":1130559,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-29T21:38:28.000Z","date":"2025-05-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-014913","document":"form4-05292025_090525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925014913/form4-05292025_090525.xml","form_type":"4"}},{"id":1163377,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-30T22:59:53.000Z","date":"2025-04-28","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":125306,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-011596","document":"form4-04302025_100450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925011596/form4-04302025_100450.xml","form_type":"4"}},{"id":1163376,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-30T22:59:53.000Z","date":"2025-04-28","kind":"sale","planned":true,"acquired":false,"shares":69,"price":19.1162,"value":1319.0178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $19.1111 to $19.1218. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-011596","document":"form4-04302025_100450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925011596/form4-04302025_100450.xml","form_type":"4"}},{"id":1163375,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-30T22:59:53.000Z","date":"2025-04-28","kind":"sale","planned":true,"acquired":false,"shares":3181,"price":18.6792,"value":59418.5352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.09 to $19.0724. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23069,"source":{"system":"sec-edgar","filing":"0001415889-25-011596","document":"form4-04302025_100450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925011596/form4-04302025_100450.xml","form_type":"4"}},{"id":1163374,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-30T22:59:53.000Z","date":"2025-04-28","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-011596","document":"form4-04302025_100450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925011596/form4-04302025_100450.xml","form_type":"4"}},{"id":1187971,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-31T23:37:34.000Z","date":"2025-03-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":128556,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-009301","document":"form4-03312025_110331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009301/form4-03312025_110331.xml","form_type":"4"}},{"id":1187970,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-31T23:37:34.000Z","date":"2025-03-27","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":21.3295,"value":69320.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.75 to $21.645. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-009301","document":"form4-03312025_110331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009301/form4-03312025_110331.xml","form_type":"4"}},{"id":1187969,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-31T23:37:34.000Z","date":"2025-03-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001415889-25-009301","document":"form4-03312025_110331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009301/form4-03312025_110331.xml","form_type":"4"}},{"id":1190899,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-26T23:37:53.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":131806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-25-009066","document":"form4-03262025_110349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009066/form4-03262025_110349.xml","form_type":"4"}},{"id":1190898,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-26T23:37:53.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":22.5045,"value":22504.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-009066","document":"form4-03262025_110349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009066/form4-03262025_110349.xml","form_type":"4"}},{"id":1190897,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-26T23:37:53.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":2.48,"value":2480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001415889-25-009066","document":"form4-03262025_110349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925009066/form4-03262025_110349.xml","form_type":"4"}},{"id":1219562,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-06T23:02:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":132806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-007286","document":"form4-03062025_110331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925007286/form4-03062025_110331.xml","form_type":"4"}},{"id":1219561,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-06T23:02:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.48,"value":24800.0,"ownership":{"direct":true},"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-007286","document":"form4-03062025_110331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925007286/form4-03062025_110331.xml","form_type":"4"}},{"id":1235812,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T01:07:10.000Z","date":"2025-02-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":142806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-006296","document":"form4-03042025_010306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925006296/form4-03042025_010306.xml","form_type":"4"}},{"id":1235811,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:07:10.000Z","date":"2025-02-27","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":20.4083,"value":66326.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.98 to $20.8818. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001415889-25-006296","document":"form4-03042025_010306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925006296/form4-03042025_010306.xml","form_type":"4"}},{"id":1235810,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:07:10.000Z","date":"2025-02-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":16250,"source":{"system":"sec-edgar","filing":"0001415889-25-006296","document":"form4-03042025_010306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925006296/form4-03042025_010306.xml","form_type":"4"}},{"id":1276593,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-10T22:27:11.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":171000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option will vest on February 6, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":171000,"derivative":{"exercise_price":22.47,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":171000},"source":{"system":"sec-edgar","filing":"0001415889-25-003511","document":"form4-02102025_100207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925003511/form4-02102025_100207.xml","form_type":"4"}},{"id":1278771,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-08T00:06:46.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":146056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-25-003405","document":"form4-02082025_120242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925003405/form4-02082025_120242.xml","form_type":"4"}},{"id":1278770,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-08T00:06:46.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":22.5244,"value":22524.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.50 to $22.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001415889-25-003405","document":"form4-02082025_120242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925003405/form4-02082025_120242.xml","form_type":"4"}},{"id":1278769,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-08T00:06:46.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":2.48,"value":2480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001415889-25-003405","document":"form4-02082025_120242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925003405/form4-02082025_120242.xml","form_type":"4"}},{"id":1291830,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-30T00:21:27.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":147056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001415889-25-002298","document":"form4-01302025_120123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925002298/form4-01302025_120123.xml","form_type":"4"}},{"id":1291829,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-30T00:21:27.000Z","date":"2025-01-27","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":21.5932,"value":70177.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.14 to $22.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001415889-25-002298","document":"form4-01302025_120123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925002298/form4-01302025_120123.xml","form_type":"4"}},{"id":1291828,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-30T00:21:27.000Z","date":"2025-01-27","kind":"exercise","planned":true,"acquired":true,"shares":3250,"price":2.48,"value":8060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":16250,"source":{"system":"sec-edgar","filing":"0001415889-25-002298","document":"form4-01302025_120123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925002298/form4-01302025_120123.xml","form_type":"4"}},{"id":1308064,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T21:43:44.000Z","date":"2025-01-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The number of derivative securities beneficially owned following the option exercise is as of January 3, 2025 and reflects the option exercise that occurred December 13, 2024, and reported herein, and subsequent option exercises that occurred on December 27, 2024 and December 30, 2024 as reported in a Form 4 filed by the Reporting Person on December 31, 2024"}],"balance_after":150306,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-25-001007","document":"form4-01072025_090141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925001007/form4-01072025_090141.xml","form_type":"4"}},{"id":1308063,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T21:43:44.000Z","date":"2024-12-13","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of derivative securities beneficially owned following the option exercise was as of December 13, 2024 and does not reflect subsequent option exercises that occurred on December 27, 2024 and December 30, 2024 as reported in a Form 4 filed by the Reporting Person on December 31, 2024."}],"balance_after":155556,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001415889-25-001007","document":"form4-01072025_090141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925001007/form4-01072025_090141.xml","form_type":"4"}},{"id":1308062,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T21:43:44.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":25.0386,"value":25038.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $25.00 to $25.045. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001415889-25-001007","document":"form4-01072025_090141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925001007/form4-01072025_090141.xml","form_type":"4"}},{"id":1308061,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T21:43:44.000Z","date":"2025-01-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":2.48,"value":2480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001415889-25-001007","document":"form4-01072025_090141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925001007/form4-01072025_090141.xml","form_type":"4"}},{"id":1308060,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T21:43:44.000Z","date":"2024-12-13","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":2.48,"value":32240.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001415889-25-001007","document":"form4-01072025_090141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925001007/form4-01072025_090141.xml","form_type":"4"}},{"id":1319833,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":164306,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1319832,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-27","kind":"exercise","planned":true,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":165206,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1319831,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-30","kind":"sale","planned":true,"acquired":false,"shares":900,"price":22.5061,"value":20255.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $22.50 to $22.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1319830,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":true,"shares":900,"price":2.48,"value":2232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1319829,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-27","kind":"sale","planned":true,"acquired":false,"shares":3350,"price":22.1549,"value":74218.915,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.58 to $22.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1319828,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-31T22:18:12.000Z","date":"2024-12-27","kind":"exercise","planned":true,"acquired":true,"shares":3350,"price":2.48,"value":8308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":3350,"source":{"system":"sec-edgar","filing":"0001415889-24-030323","document":"form4-12312024_101209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924030323/form4-12312024_101209.xml","form_type":"4"}},{"id":1347173,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-02T22:18:40.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":false,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":168556,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-24-028001","document":"form4-12022024_101235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924028001/form4-12022024_101235.xml","form_type":"4"}},{"id":1347172,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-02T22:18:40.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":25.3755,"value":25375.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $25.26 to $25.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-028001","document":"form4-12022024_101235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924028001/form4-12022024_101235.xml","form_type":"4"}},{"id":1347171,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-02T22:18:40.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":4250,"price":24.7795,"value":105312.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.25 to $25.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001415889-24-028001","document":"form4-12022024_101235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924028001/form4-12022024_101235.xml","form_type":"4"}},{"id":1347170,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-02T22:18:40.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":true,"shares":5250,"price":2.48,"value":13020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001415889-24-028001","document":"form4-12022024_101235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924028001/form4-12022024_101235.xml","form_type":"4"}},{"id":1379370,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-30T22:04:43.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":173806,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-24-025779","document":"form4-10302024_101039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025779/form4-10302024_101039.xml","form_type":"4"}},{"id":1379369,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-30T22:04:43.000Z","date":"2024-10-28","kind":"sale","planned":true,"acquired":false,"shares":650,"price":29.111,"value":18922.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $28.97 to $29.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-025779","document":"form4-10302024_101039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025779/form4-10302024_101039.xml","form_type":"4"}},{"id":1379368,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-30T22:04:43.000Z","date":"2024-10-28","kind":"sale","planned":true,"acquired":false,"shares":5600,"price":28.4933,"value":159562.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.97 to $28.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":650,"source":{"system":"sec-edgar","filing":"0001415889-24-025779","document":"form4-10302024_101039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025779/form4-10302024_101039.xml","form_type":"4"}},{"id":1379367,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-30T22:04:43.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":true,"shares":6250,"price":2.48,"value":15500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-24-025779","document":"form4-10302024_101039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025779/form4-10302024_101039.xml","form_type":"4"}},{"id":1382949,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:19:58.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":180056,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":814},"source":{"system":"sec-edgar","filing":"0001415889-24-025501","document":"form4-10222024_081055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025501/form4-10222024_081055.xml","form_type":"4"}},{"id":1382948,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-22T20:19:58.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":814,"price":30.003,"value":24422.442,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-025501","document":"form4-10222024_081055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025501/form4-10222024_081055.xml","form_type":"4"}},{"id":1382947,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-22T20:19:58.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":814,"price":2.48,"value":2018.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":814,"source":{"system":"sec-edgar","filing":"0001415889-24-025501","document":"form4-10222024_081055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924025501/form4-10222024_081055.xml","form_type":"4"}},{"id":1389334,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":false,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":180870,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":1270},"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1389333,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-04","kind":"exercise","planned":true,"acquired":false,"shares":10218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":182140,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":10218},"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1389332,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":1270,"price":27.5081,"value":34935.287,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $27.50 to $27.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1389331,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":true,"shares":1270,"price":2.48,"value":3149.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1389330,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-04","kind":"sale","planned":true,"acquired":false,"shares":10218,"price":27.5082,"value":281078.7876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.50 to $27.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1389329,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-08T22:56:05.000Z","date":"2024-10-04","kind":"exercise","planned":true,"acquired":true,"shares":10218,"price":2.48,"value":25340.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":10218,"source":{"system":"sec-edgar","filing":"0001415889-24-024900","document":"form4-10082024_101002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024900/form4-10082024_101002.xml","form_type":"4"}},{"id":1392048,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-03T22:44:54.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter."}],"balance_after":192358,"derivative":{"exercise_price":2.48,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":521},"source":{"system":"sec-edgar","filing":"0001415889-24-024669","document":"form4-10032024_101051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024669/form4-10032024_101051.xml","form_type":"4"}},{"id":1392047,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T22:44:54.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":521,"price":27.5372,"value":14346.8812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.52 to $27.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-024669","document":"form4-10032024_101051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024669/form4-10032024_101051.xml","form_type":"4"}},{"id":1392046,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":21638,"kind":"person","name":"Hohl Benjamin","position":1,"cik":"0001882764","reported_name":"Hohl Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T22:44:54.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":521,"price":2.48,"value":1292.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":521,"source":{"system":"sec-edgar","filing":"0001415889-24-024669","document":"form4-10032024_101051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924024669/form4-10032024_101051.xml","form_type":"4"}}],"next_cursor":"2024-10-03T22:44:54.000000Z,1392046"}